von Itzstein, M.S.; Gonugunta, A.S.; Sheffield, T.; Homsi, J.; Dowell, J.E.; Koh, A.Y.; Raj, P.; Fattah, F.; Wang, Y.; Basava, V.S.;
et al. Association between Antibiotic Exposure and Systemic Immune Parameters in Cancer Patients Receiving Checkpoint Inhibitor Therapy. Cancers 2022, 14, 1327.
https://doi.org/10.3390/cancers14051327
AMA Style
von Itzstein MS, Gonugunta AS, Sheffield T, Homsi J, Dowell JE, Koh AY, Raj P, Fattah F, Wang Y, Basava VS,
et al. Association between Antibiotic Exposure and Systemic Immune Parameters in Cancer Patients Receiving Checkpoint Inhibitor Therapy. Cancers. 2022; 14(5):1327.
https://doi.org/10.3390/cancers14051327
Chicago/Turabian Style
von Itzstein, Mitchell S., Amrit S. Gonugunta, Thomas Sheffield, Jade Homsi, Jonathan E. Dowell, Andrew Y. Koh, Prithvi Raj, Farjana Fattah, Yiqing Wang, Vijay S. Basava,
and et al. 2022. "Association between Antibiotic Exposure and Systemic Immune Parameters in Cancer Patients Receiving Checkpoint Inhibitor Therapy" Cancers 14, no. 5: 1327.
https://doi.org/10.3390/cancers14051327
APA Style
von Itzstein, M. S., Gonugunta, A. S., Sheffield, T., Homsi, J., Dowell, J. E., Koh, A. Y., Raj, P., Fattah, F., Wang, Y., Basava, V. S., Khan, S., Park, J. Y., Popat, V., Saltarski, J. M., Gloria-McCutchen, Y., Hsiehchen, D., Ostmeyer, J., Xie, Y., Li, Q.-Z.,
... Gerber, D. E.
(2022). Association between Antibiotic Exposure and Systemic Immune Parameters in Cancer Patients Receiving Checkpoint Inhibitor Therapy. Cancers, 14(5), 1327.
https://doi.org/10.3390/cancers14051327
